Form 8-K - Current report:
SEC Accession No. 0001193125-25-140718
Filing Date
2025-06-13
Accepted
2025-06-13 16:01:43
Documents
12
Period of Report
2025-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d89465d8k.htm   iXBRL 8-K 33336
  Complete submission text file 0001193125-25-140718.txt   155095

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bmea-20250611.xsd EX-101.SCH 2865
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmea-20250611_lab.xml EX-101.LAB 19500
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmea-20250611_pre.xml EX-101.PRE 12166
14 EXTRACTED XBRL INSTANCE DOCUMENT d89465d8k_htm.xml XML 3888
Mailing Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063
Business Address 900 MIDDLEFIELD ROAD 4TH FLOOR REDWOOD CITY CA 94063 (650) 980-9099
Biomea Fusion, Inc. (Filer) CIK: 0001840439 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40335 | Film No.: 251046324
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)